Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
Public ClinicalTrials.gov record NCT03724136. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the use of autologous Bone Marrow Derived Stem Cells (BMSC) as a means to improve cognitive impairment as occurs in Alzheimer's Disease and other dementias and to improve behavior and socialization issues which occur in adult Autism Spectrum Disorder. The use of Near Infrared Light, in conjunction with the use of BMSC, will also be assessed.
Study identification
- NCT ID
- NCT03724136
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 100 participants
Conditions and interventions
Conditions
- Alzheimer Disease
- Alzheimer Dementia
- Vascular Dementia
- Lewy Body Disease
- Lewy Body Dementia With Behavioral Disturbance (Disorder)
- Dementia, Mixed
- Parkinson-Dementia Syndrome
- Chronic Traumatic Encephalopathy
- Huntington's Dementia
- Wernicke Korsakoff Syndrome
- Traumatic Brain Injury
- Dementia, Multi-Infarct
- Autism
- Autism Spectrum Disorder
- Autistic Behavior
- Autistic Disorder, Current or Active State
- Cadasil
- LATE Limbic-predominant Age-related TDP-43 Encephalopathy
Interventions
- Intravenous Bone Marrow Stem Cell (BMSC) Fraction Procedure
- Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction Procedure
- Near Infrared Light Procedure
Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 23, 2018
- Primary completion
- Jul 30, 2025
- Completion
- Jul 30, 2025
- Last update posted
- Apr 14, 2024
2018 – 2025
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| MD Stem Cells | Westport | Connecticut | 06880 | — |
| MD Stem Cells | Coral Springs | Florida | 33065 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03724136, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2024 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03724136 live on ClinicalTrials.gov.